Invesaro

Stocks AP Financial statements

Financial statements

AMPCO PITTSBURGH CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data AMPCO PITTSBURGH CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue332432419398329345390422418434
Cost of revenue352326258279328348337354
Gross profit67.671.77166.162.274.681.580
Research and development2.723.392.662.522.051.231.020.660.440.49
Selling, general and administrative58.260.258.153.645.54643.550.954.952.1
Operating expenses386399464
Operating income-54.5-13.8-44.9-10.96.45-4.782.78-34.612.2-54.5
Interest expense2.43.094.135.344.113.65.439.3511.611.4
Interest income0.480.130.531.421.41.080.520.130.12
Other non-operating income-2.99-3.671.092.542.253.792.78-4.7-7.12-8.94
Pre-tax income-57.5-17.4-43.8-8.378.7-15.56-39.35.05-63.4
Income tax22.7-1.360.272.11-0.472.311.58-1.162.70.12
Net income to minority interests0.010.791.861.431.20.560.561.811.912.53
Net income-79.8-12.1-69.3-217.97-3.863.42-39.90.44-66.1
EBITDA-34.17.61-23.58.062513.120.2-16.930.8-32.7
EPS, basic-1.99-0.29-1.66-0.500.17-0.200.18-2.040.02-3.28
EPS, diluted-1.99-0.29-1.66-0.500.16-0.200.18-2.040.02-3.28
Shares, basic (weighted)4041.341.742.247.81919.319.619.920.1
Shares, diluted (weighted)4041.341.742.2491919.419.619.920.1
Dividend per share0.110.03

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents38.618.719.76.9616.810.38.747.2915.410.7
Receivables72.281.569.481.860.468.872.578.970.679
Inventory83.693.594.282.373.2109122125117104
Other current assets14.111.37.276.385.384.937.445.378.666.83
Total current assets221240228193172209231237237240
Property, plant and equipment214204186166162159155159148129
Lease right-of-use assets04.264.344.063.524.774.594.67
Intangible assets11.6119.237.637.226.25.194.954.264.63
Other non-current assets8.637.667.58.765.796.95.185.024.234.73
Total assets566566571507463506503566531495
Accounts payable37.135.438.933.326.743.143.236.836.346.3
Accrued liabilities20.222.320.422.319.31611.814.717.113.4
Deferred revenue6.794.574.34.96.514.3310.513.11910
Short-term debt26.819.345.720.412.42012.412.312.215.7
Total current liabilities144145167124105125116117125130
Long-term debt25.446.831.950.524.840.993.1116116118
Lease liabilities03.653.673.422.893.823.713.73
Other non-current liabilities0.660.422.071.462.971.170.680.092.742.8
Total liabilities416404478451378394389494460447
Total debt52.266.277.670.937.260.9105129129134
Paid-in capital151153155156170175176177178179
Retained earnings45.438.3-30.4-51.3-43.4-35.7-32.3-73-72.6-139
Other comprehensive income-60.9-44.8-49.4-68.7-68.7-55.1-58.4-63-66.8-28.2
Shareholders' equity14815987.648.976.610310460.958.932.6
Minority interests1.922.825.376.728.449.239.0710.612.215.3
Total equity1501629355.696.511211371.671.148
Total liabilities and equity566566571507463506503566531495
Shares outstanding41.141.441.942.461.319.219.419.72020.2

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-79.8-11.3-67.5-19.69.17-3.33.98-38.12.35-63.5
Depreciation and amortization20.521.421.41918.617.917.417.718.621.8
Stock-based compensation2.332.42.121.421.332.441.672.151.481.35
Deferred income tax23.43.18-1.810.560.961.30.47-2.960.26-1.21
Change in receivables5.7-13.28.92-1520.9-8.27-11.6-5.476.15-7.38
Change in inventory8.31-13.8-5.410.810.2-27.6-17.9-1.44.767.37
Change in payables-8.821.175.22-5.29-7.7817.61.56-6.36-0.111.4
Cash from operations-5.63-196.71-3.2933.6-15.9-27.2-3.69181.34
Capital expenditures-10.6-13-9.72-11-8.47-15.2-16.7-20.4-12.2-9.41
Acquisitions-270
Purchases of investments-0.11-0.11-0.03-0.72-0.1-0.37-0.05
Sales and maturities of investments0.330.310.31.090.731.010.66
Cash from investing-40.9-11.3-1.22-2.66-7.93-14.7-16.3-19.7-8.25-9.22
Debt repaid-1.21-28.2-6.76-0.86-0.65-0.47-2.38-6.63
Stock issued0
Dividends paid-5.21-2.24-0.04
Cash from financing-8.888.93-3.42-6.62-17.224.442.621.7-1.352.21
Exchange rate effect1.49-1.01-0.181.4-0.31-0.670.23-0.290.94
Net change in cash-56.5-17.90.14-13.99.88-6.51-1.6-1.458.14-4.72
Free cash flow-16.2-32.1-3.01-14.325.2-31.1-43.9-24.15.83-8.06
Interest paid0.961.281.954.252.982.95.927.9210.29.76
Income taxes paid4.40.841.421.762.171.630.92.342.511.82

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $8.64 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin18.8%Gross profit / revenue.
Operating margin-11.1%Operating income / revenue.
EBITDA margin-6.4%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-13.1%Pre-tax income / revenue.
Net margin-13.8%Net income / revenue.
FCF margin-0.9%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin2.5%Cash from operations / revenue.
Return on equity (ROE)-190.4%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-12.1%Net income / average total assets.
Return on invested capital (ROIC)-23.3%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue12.2%Selling, general and administrative expense / revenue.
Stock-based pay / revenue0.3%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue3.5%Capital expenditures / revenue.
D&A / revenue4.7%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y3.8%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y3.6%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y5.7%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-1.9%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y8.7%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y2.4%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y-547.7%Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y-206.2%EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y-15,184.0%Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y-16,500.0%EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y-92.5%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y-47.5%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-238.2%Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y-44.6%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-32.1%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-15.7%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-6.7%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-0.5%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y1.4%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y1.3%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y1.2%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-16.3%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.78xCurrent assets / current liabilities.
Quick ratio0.67x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.05x(Cash + short-term investments) / current liabilities.
Debt / equity4.42xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets28.0%Total debt / total assets.
Liabilities / assets90.2%Total liabilities / total assets.
Net debt$130.5MTotal debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage-4.20xOperating income / interest expense.
Working capital$108.3MCurrent assets - current liabilities.
Goodwill and intangibles / assets0.9%(Goodwill + intangible assets) / total assets.
Tangible book value$26.8MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.87xRevenue / average total assets.
Fixed asset turnover3.37xRevenue / average property, plant and equipment.
Inventory turnover3.05xCost of revenue / average inventory.
Days inventory119 days365 x average inventory / cost of revenue.
Receivables turnover4.96xRevenue / average receivables.
Days sales outstanding74 days365 x average receivables / revenue.
Days payables47 days365 x average accounts payable / cost of revenue.
Cash conversion cycle146 daysDays inventory + days sales outstanding - days payables.
Capex / operating cash flow136.6%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted-$2.76Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$19.97Revenue / diluted weighted shares.
FCF per share-$0.19Free cash flow / diluted weighted shares.
Operating cash flow per share$0.51Cash from operations / diluted weighted shares.
Book value per share$1.51Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$1.30Tangible book value / shares outstanding.
Cash per share$0.34(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$178.5MShare price x shares outstanding.
Enterprise value$309.0MMarket cap + total debt - cash - short-term investments.
P/S0.42xMarket cap / revenue.
P/B5.74xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book6.67xMarket cap / tangible book value, when positive.
P/OCF16.4xMarket cap / cash from operations, when positive.
EV/Sales0.72xEnterprise value / revenue.
FCF yield-2.2%Free cash flow / market cap.
Earnings yield-33.2%Net income / market cap (the inverse of P/E).
What was AMPCO PITTSBURGH CORP's revenue in fiscal 2025?

AMPCO PITTSBURGH CORP reported revenue of $434.2M for fiscal 2025, 3.8% higher than the year before.

Was AMPCO PITTSBURGH CORP profitable in fiscal 2025?

No. It reported a net loss of $66.1M.

How much free cash flow did AMPCO PITTSBURGH CORP generate in fiscal 2025?

Cash from operations of $1.3M minus capital expenditures of $9.4M left free cash flow of -$8.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to AMPCO PITTSBURGH CORP